Enrollment complete in Phase 2 Avail™ trial of canvuparatide in hypoparathyroidism; topline results on track for Q3 2025. MBX 1416 Phase 2 trial in patients with post-bariatric ...

Monogram Technologies announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Monogram mBos TKA System. This ...

Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act).

Normani and D.K. Metcalf are engaged, the newly minted Pittsburgh Steeler announces. He popped the question to the R&B singer ...

Fresh faces mean fresh starts, and one of the NFL’s most physically imposing wide receivers is embracing that spirit as he ...

MGRM READ THE FULL MGRM RESEARCH REPORT 4th Quarter and Full Year 2024 Financial Results Monogram (NASDAQ:MGRM) reported 4th ...

Q4 2024 Earnings Call Transcript March 12, 2025 Larry Holub: Good afternoon everyone. I’m Larry Holub, Director at MZ North America, and would like to welcome you to the Monogram Technologies fourth ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

At the ribbon cutting are: Parker Roop (from left) and Joe Aguilar with Patrick Building Supply; Antwain Mitchell, Andrew Payne, Eli Wood, Paul Pascale, and Instructor Philip Steagall with Patrick ...

Monogram Technologies Inc. ( NASDAQ: MGRM) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noel Knape - Chief ...

AUSTIN, TEXAS / ACCESS Newswire / March 12, 2025 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics company focused on improving human health with an ...

Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Information Request (AIR)Management to Host ...